Our findings identified 350 morusin-related targets and 2913 targets associated with NPC, suggesting that the “IL-17 signaling pathway” and “PI3K-AKT signaling pathway” may be the primary potential targets implicated in NPC treatment. Here, AKT1 is linked to nasopharyngeal carcinoma.